NIH 2008 N01 HL |
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension / University of Colorado Denver |
$385,356 |
NIH 2007 N01 HL |
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension Badesch, David / |
$360,397 |
NIH 2007 N01 HL |
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension / |
|